[144] Standex International Corporation SEC Filing

Rhea-AI Filing Summary

Standex International Corp. (SXI) filed a Form 144 indicating a proposed sale of 3,047 common shares on or about 08-06-2025 through Fidelity Brokerage Services on the NYSE. The shares originate from three restricted-stock vesting events (2,083 on 09-06-2023, 464 on 08-23-2024, and 500 on 04-01-2025) received as compensation. At the most recent market price used by the filer, the aggregate value is $584,446.61.

The notice covers approximately 0.03 % of SXI’s 12,068,262 shares outstanding, suggesting limited potential market impact. No sales were reported in the prior three months, and the filer attests to lacking undisclosed adverse information, as required by Rule 144. Relationship to the issuer and other personal details were not disclosed in the filing.

Positive

• Transparency: Timely Rule 144 filing provides advance notice of potential insider sale.
• Immaterial size: Proposed sale equals only ~0.03 % of shares outstanding, limiting market impact.

Negative

• Insider selling signal: Any affiliate sale can be perceived negatively, though scale is minor.
• No disclosed 10b5-1 plan: Absence of a pre-arranged trading plan may raise modest optics concerns.

Insights

Securities Analyst

TL;DR: Minor Rule 144 sale worth ~$0.6 M; negligible 0.03 % of float—low market impact.

The filing signals an affiliate or insider intends to liquidate recently vested restricted stock. Size is immaterial relative to SXI’s float and daily trading volume, so price pressure should be minimal. Absence of prior 3-month sales and the Rule 144 representation lessen concerns about informational asymmetry. Overall, this is a routine liquidity event rather than a value-changing signal.

Corporate Governance Expert

TL;DR: Standard compliance disclosure; no governance red flags detected.

The filer follows Rule 144 protocol, providing full acquisition history and confirming no undisclosed adverse information. Because the shares stem from compensation-based vesting rather than open-market purchases, the transaction aligns with normal executive reward monetization practices. Lack of a disclosed 10b5-1 plan slightly elevates optics risk but is not material given the small size.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3047	584446.61	12068262	08/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/06/2023	Restricted Stock Vesting	Issuer			2083	09/06/2023	Compensation
Common	08/23/2024	Restricted Stock Vesting	Issuer			464	08/23/2024	Compensation
Common	04/01/2025	Restricted Stock Vesting	Issuer			500	04/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Standex (SXI) shares are being sold under this Form 144?

The notice covers 3,047 common shares.

What is the total market value of the shares listed in SXI's Form 144?

The filer valued the shares at $584,446.61 in aggregate.

What percentage of Standex's outstanding shares does this sale represent?

Approximately 0.03 % of the 12,068,262 shares outstanding.

When is the approximate sale date for the SXI shares?

The filer indicates an 08-06-2025 sale date.

Where will the shares be sold?

Through Fidelity Brokerage Services LLC on the NYSE.

Were any SXI shares sold by this filer in the last three months?

No, the filing states "Nothing to Report" for the past three months.